What motivates use of community-based human immunodeficiency virus testing in rural South Africa?
Identifieur interne : 000923 ( Pmc/Checkpoint ); précédent : 000922; suivant : 000924What motivates use of community-based human immunodeficiency virus testing in rural South Africa?
Auteurs : Devesh Upadhya [États-Unis] ; Anthony P. Moll [Afrique du Sud] ; Ralph P. Brooks [États-Unis] ; Gerald Friedland [États-Unis] ; Sheela V. Shenoi [États-Unis]Source :
- International journal of STD & AIDS [ 0956-4624 ] ; 2015.
Abstract
Despite substantial progress in implementing human immunodeficiency virus testing, challenges remain in achieving widespread uptake particularly in rural resource-limited settings. We sought to understand motivations for human immunodeficiency virus testing in a community-based human immunodeficiency virus testing programme in rural South Africa. We conducted a questionnaire survey in participants undergoing voluntary human immunodeficiency virus testing within an ongoing community-based integrated human immunodeficiency virus/TB intensive case finding programme at congregate rural settings. Participants responded to a six-item non-mutually exclusive motivations survey which included the topics of feeling ill, recent HV exposure, risky lifestyle, illness in a family member, and pregnancy. Among 2068 respondents completing the survey, 1393 (67.4%) were women, median age was 40 years (IQR 19–56), and 1235 (59.7%) were first time testers. Among all testers, 142 (6.9%) were human immunodeficiency virus-positive with median CD4 count 346 (IQR 218–542). Community-based testing for human immunodeficiency virus is acceptable and meets the needs of community members in rural South Africa. Motivations for human immunodeficiency virus testing at the community level are complex and differ according to gender, age, site of community testing, and human immunodeficiency virus status. These differences can be utilised to improve the focus and yield of community-based human immunodeficiency virus screening.
Url:
DOI: 10.1177/0956462415592789
PubMed: 26134323
PubMed Central: 4851612
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:4851612Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What motivates use of community-based human immunodeficiency virus testing in rural South Africa?</title>
<author><name sortKey="Upadhya, Devesh" sort="Upadhya, Devesh" uniqKey="Upadhya D" first="Devesh" last="Upadhya">Devesh Upadhya</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Internal Medicine, Baylor School of Medicine, Baylor, TX, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Baylor School of Medicine, Baylor, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moll, Anthony P" sort="Moll, Anthony P" uniqKey="Moll A" first="Anthony P" last="Moll">Anthony P. Moll</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Church of Scotland Hospital, ARV Programme, Tugela Ferry, South Africa</nlm:aff>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Church of Scotland Hospital, ARV Programme, Tugela Ferry</wicri:regionArea>
<wicri:noRegion>Tugela Ferry</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brooks, Ralph P" sort="Brooks, Ralph P" uniqKey="Brooks R" first="Ralph P" last="Brooks">Ralph P. Brooks</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedland, Gerald" sort="Friedland, Gerald" uniqKey="Friedland G" first="Gerald" last="Friedland">Gerald Friedland</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shenoi, Sheela V" sort="Shenoi, Sheela V" uniqKey="Shenoi S" first="Sheela V" last="Shenoi">Sheela V. Shenoi</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">26134323</idno>
<idno type="pmc">4851612</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851612</idno>
<idno type="RBID">PMC:4851612</idno>
<idno type="doi">10.1177/0956462415592789</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">001E52</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001E52</idno>
<idno type="wicri:Area/Pmc/Curation">001E51</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001E51</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000923</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000923</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">What motivates use of community-based human immunodeficiency virus testing in rural South Africa?</title>
<author><name sortKey="Upadhya, Devesh" sort="Upadhya, Devesh" uniqKey="Upadhya D" first="Devesh" last="Upadhya">Devesh Upadhya</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Internal Medicine, Baylor School of Medicine, Baylor, TX, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Baylor School of Medicine, Baylor, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moll, Anthony P" sort="Moll, Anthony P" uniqKey="Moll A" first="Anthony P" last="Moll">Anthony P. Moll</name>
<affiliation wicri:level="1"><nlm:aff id="A2">Church of Scotland Hospital, ARV Programme, Tugela Ferry, South Africa</nlm:aff>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Church of Scotland Hospital, ARV Programme, Tugela Ferry</wicri:regionArea>
<wicri:noRegion>Tugela Ferry</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Brooks, Ralph P" sort="Brooks, Ralph P" uniqKey="Brooks R" first="Ralph P" last="Brooks">Ralph P. Brooks</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Friedland, Gerald" sort="Friedland, Gerald" uniqKey="Friedland G" first="Gerald" last="Friedland">Gerald Friedland</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Shenoi, Sheela V" sort="Shenoi, Sheela V" uniqKey="Shenoi S" first="Sheela V" last="Shenoi">Sheela V. Shenoi</name>
<affiliation wicri:level="2"><nlm:aff id="A3">Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of STD & AIDS</title>
<idno type="ISSN">0956-4624</idno>
<idno type="eISSN">1758-1052</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">Despite substantial progress in implementing human immunodeficiency virus testing, challenges remain in achieving widespread uptake particularly in rural resource-limited settings. We sought to understand motivations for human immunodeficiency virus testing in a community-based human immunodeficiency virus testing programme in rural South Africa. We conducted a questionnaire survey in participants undergoing voluntary human immunodeficiency virus testing within an ongoing community-based integrated human immunodeficiency virus/TB intensive case finding programme at congregate rural settings. Participants responded to a six-item non-mutually exclusive motivations survey which included the topics of feeling ill, recent HV exposure, risky lifestyle, illness in a family member, and pregnancy. Among 2068 respondents completing the survey, 1393 (67.4%) were women, median age was 40 years (IQR 19–56), and 1235 (59.7%) were first time testers. Among all testers, 142 (6.9%) were human immunodeficiency virus-positive with median CD4 count 346 (IQR 218–542). Community-based testing for human immunodeficiency virus is acceptable and meets the needs of community members in rural South Africa. Motivations for human immunodeficiency virus testing at the community level are complex and differ according to gender, age, site of community testing, and human immunodeficiency virus status. These differences can be utilised to improve the focus and yield of community-based human immunodeficiency virus screening.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9007917</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1045</journal-id>
<journal-id journal-id-type="nlm-ta">Int J STD AIDS</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J STD AIDS</journal-id>
<journal-title-group><journal-title>International journal of STD & AIDS</journal-title>
</journal-title-group>
<issn pub-type="ppub">0956-4624</issn>
<issn pub-type="epub">1758-1052</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">26134323</article-id>
<article-id pub-id-type="pmc">4851612</article-id>
<article-id pub-id-type="doi">10.1177/0956462415592789</article-id>
<article-id pub-id-type="manuscript">NIHMS707926</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>What motivates use of community-based human immunodeficiency virus testing in rural South Africa?</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Upadhya</surname>
<given-names>Devesh</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Moll</surname>
<given-names>Anthony P</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Brooks</surname>
<given-names>Ralph P</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Friedland</surname>
<given-names>Gerald</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Shenoi</surname>
<given-names>Sheela V</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>
Department of Internal Medicine, Baylor School of Medicine, Baylor, TX, USA</aff>
<aff id="A2"><label>2</label>
Church of Scotland Hospital, ARV Programme, Tugela Ferry, South Africa</aff>
<aff id="A3"><label>3</label>
Department of Internal Medicine, Section of Infectious Diseases, AIDS Program, Yale University School of Medicine, New Haven, CT, USA</aff>
<author-notes><corresp id="FN1"><bold>Corresponding author:</bold>
Sheela Shenoi, 135 College Street, Suite 323, New Haven, CT 06510, USA. <email>Sheela.Shenoi@yale.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted"><day>26</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub"><day>01</day>
<month>7</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub"><month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release"><day>01</day>
<month>7</month>
<year>2017</year>
</pub-date>
<volume>27</volume>
<issue>8</issue>
<fpage>662</fpage>
<lpage>671</lpage>
<pmc-comment>elocation-id from pubmed: 10.1177/0956462415592789</pmc-comment>
<abstract><p id="P1">Despite substantial progress in implementing human immunodeficiency virus testing, challenges remain in achieving widespread uptake particularly in rural resource-limited settings. We sought to understand motivations for human immunodeficiency virus testing in a community-based human immunodeficiency virus testing programme in rural South Africa. We conducted a questionnaire survey in participants undergoing voluntary human immunodeficiency virus testing within an ongoing community-based integrated human immunodeficiency virus/TB intensive case finding programme at congregate rural settings. Participants responded to a six-item non-mutually exclusive motivations survey which included the topics of feeling ill, recent HV exposure, risky lifestyle, illness in a family member, and pregnancy. Among 2068 respondents completing the survey, 1393 (67.4%) were women, median age was 40 years (IQR 19–56), and 1235 (59.7%) were first time testers. Among all testers, 142 (6.9%) were human immunodeficiency virus-positive with median CD4 count 346 (IQR 218–542). Community-based testing for human immunodeficiency virus is acceptable and meets the needs of community members in rural South Africa. Motivations for human immunodeficiency virus testing at the community level are complex and differ according to gender, age, site of community testing, and human immunodeficiency virus status. These differences can be utilised to improve the focus and yield of community-based human immunodeficiency virus screening.</p>
</abstract>
<kwd-group><kwd>Africa</kwd>
<kwd>diagnosis</kwd>
<kwd>human immunodeficiency virus</kwd>
<kwd>screening</kwd>
<kwd>epidemiology</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
<affiliations><list><country><li>Afrique du Sud</li>
<li>États-Unis</li>
</country>
<region><li>Connecticut</li>
<li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Upadhya, Devesh" sort="Upadhya, Devesh" uniqKey="Upadhya D" first="Devesh" last="Upadhya">Devesh Upadhya</name>
</region>
<name sortKey="Brooks, Ralph P" sort="Brooks, Ralph P" uniqKey="Brooks R" first="Ralph P" last="Brooks">Ralph P. Brooks</name>
<name sortKey="Friedland, Gerald" sort="Friedland, Gerald" uniqKey="Friedland G" first="Gerald" last="Friedland">Gerald Friedland</name>
<name sortKey="Shenoi, Sheela V" sort="Shenoi, Sheela V" uniqKey="Shenoi S" first="Sheela V" last="Shenoi">Sheela V. Shenoi</name>
</country>
<country name="Afrique du Sud"><noRegion><name sortKey="Moll, Anthony P" sort="Moll, Anthony P" uniqKey="Moll A" first="Anthony P" last="Moll">Anthony P. Moll</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000923 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000923 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:4851612 |texte= What motivates use of community-based human immunodeficiency virus testing in rural South Africa? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:26134323" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SidaSubSaharaV1
![]() | This area was generated with Dilib version V0.6.32. | ![]() |